Keytruda (pembrolizumab) - Merck (MSD)
CTM-103 - iLeukon Therapeutics
http://dx.doi.org/10.1136/jitc-2024-SITC2024.1494
 
Chengying Kong 1; Jingnan Zhang 1; Li Sun 1; Qijia Xuan 1; Haining Huang 2; Kai Wang 1
 
Nov 5, 2024